Tocilizumab in Coronavirus-19 Positive Patients
NCT04423042
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Covid19
COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2
Coronavirus
Inflammation
Interventions
BIOLOGICAL:
Tocilizumab
Sponsor
University of Calgary